Yeah, I'm holding just frustrating because missing out on a couple doozies I planned on getting in. If this breaks .57 were going to .48 again! Just throw us a bone with the new patent or final results, something!!
I have to say... I like how they are doing this. If they tried to run a bunch of trials right now they would have to raise more money at this low SP... of course, causing major dilution... they obviously want CE before going into more trials... with the higher SP that comes with CE they can more efficiently raise money... and of course they could partner or be bought before that. It seems well thought out to make shareholders rewarded, and since the CEO is so heavily invested I have to go with that theory... I am in other bio companies that constantly have to raise funds at horrible SP levels.
News 
Market Data 
Discover 
AI
